الولايات المتحدة · منصات وبيانات · Yahoo Finance

Madrigal Pharmaceuticals (MDGL) Stock May Be Below Fair Value Despite First Profit

نشره Yahoo Finance · الولايات المتحدة منذ 9 س

Madrigal Pharmaceuticals has gone from a relatively small specialist to a business with more than US$1b in annualised sales from its liver drug Rezdiffra, yet the share price has…

اقرأ المقال كاملًا على Yahoo Finance سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (finance.yahoo.com)

يستحق القراءة أيضًا

Seeking Alpha

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

MarketWatch

These stocks have soared the most today after the Democrats trounced Trump

MarketBeat

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

The Motley Fool

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Investing.com

Eversource Energy earnings on deck after Q2 miss, estimate cuts

CNBC